Welcome to EQUITY DEVELOPMENT

The UK's longest established regulated provider of sponsored equity research.

We launched EQUITY DEVELOPMENT in 1997 becoming the first ever  regulated provider of Sponsored Equity Research in the UK.

Our research teams are made up of expert analysts with deep understanding & experience in their sectors.  Our research is distributed to all relevant investment classes & commentators. (at no cost to the reader).

We have made our name by specialising in those companies who are not receiving the attention that they merit, using detailed commentary, appropriate valuation metrics and regular publications to help eradicate undervaluation in the medium term.

 

FREE REGISTRATION

Sign up today and access the very latest company research

LOG IN

For access to all company research please

Regenesis

Regenesis (RGN) is a start-up venture in “Bridging Finance”, run by a team of experts with well over 80 years of experience, with the benefit of an AIM listing and the tax losses of the shell within which it is being launched.

Bridging finance vehicle

  • Regenesis targets short term asset finance
  • EGM approves name change and 1 for 10 share consolidation
  • Managed by highly experienced team of bankers

Publication Date:
May 2 2007